SGAM
MEDP icon

Smith Group Asset Management’s Medpace MEDP Stock Holding History

Smith Group Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8M Buy
109,170
+5,567
+5% +$2.57M 2.35% 14
2026
Q1 		$49.7M Buy
103,603
+8,821
+9% +$4.52M 2.54% 12
2025
Q4 		$53.2M Buy
94,782
+7,577
+9% +$4.3M 2.82% 11
2025
Q3 		$44.8M Buy
87,205
+4,982
+6% +$2.18M 2.58% 15
2025
Q2 		$25.8M Buy
82,223
+2,529
+3% +$759K 1.69% 28
2025
Q1 		$24.3M Buy
79,694
+5,436
+7% +$1.83M 1.82% 26
2024
Q4 		$24.7M Sell
74,258
-2,780
-4% -$943K 1.82% 24
2024
Q3 		$25.7M Buy
77,038
+1,809
+2% +$687K 2.13% 18
2024
Q2 		$31M Sell
75,229
-31,394
-29% -$12.4M 2.75% 12
2024
Q1 		$43.1M Sell
106,623
-7,289
-6% -$2.56M 2.47% 4
2023
Q4 		$34.9M Buy
+113,912
New +$30.7M 2.03% 7
2022
Q1 		$347K Sell
2,123
-1,681
-44% -$277K 0.02% 132
2021
Q4 		$828K Sell
3,804
-97
-2% -$20.3K 0.04% 105
2021
Q3 		$738K Sell
3,901
-468
-11% -$85.4K 0.04% 106
2021
Q2 		$772K Sell
4,369
-502
-10% -$86.6K 0.04% 95
2021
Q1 		$799K Sell
4,871
-4,080
-46% -$624K 0.04% 89
2020
Q4 		$1.25M Sell
8,951
-1,550
-15% -$195K 0.07% 92
2020
Q3 		$1.17M Sell
10,501
-2,806
-21% -$324K 0.06% 96
2020
Q2 		$1.24M Sell
13,307
-528
-4% -$44.9K 0.07% 95
2020
Q1 		$1.01M Sell
13,835
-3,155
-19% -$274K 0.06% 94
2019
Q4 		$1.43M Sell
16,990
-300
-2% -$23.2K 0.06% 98
2019
Q3 		$1.45M Sell
17,290
-2,971
-15% -$224K 0.05% 101
2019
Q2 		$1.32M Buy
20,261
+31
+0.2% +$1.79K 0.04% 109
2019
Q1 		$1.19M Sell
20,230
-27,970
-58% -$1.67M 0.04% 113
2018
Q4 		$2.55M Buy
48,200
+10,670
+28% +$586K 0.09% 104
2018
Q3 		$2.25M Buy
+37,530
New +$2.05M 0.06% 126

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Smith Group Asset Management's MEDP Position: Q2 2026 in Review

Smith Group Asset Management increased its Medpace (MEDP) stake by 5.4% in Q2 2026, buying an estimated $2.57M and bringing the position to 109,170 shares worth $57.8M. The position accounts for 2.35% of the portfolio, ranked #14.

Smith Group Asset Management first reported a position in MEDP in Q3 2018 and has held it in 26 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Smith Group Asset Management held 109,170 shares of Medpace worth $57.8M as of Q2 2026.
  • Smith Group Asset Management bought 5,567 Medpace shares in Q2 2026, an estimated $2.57M.
  • Medpace made up 2.35% of Smith Group Asset Management's portfolio in Q2 2026, its #14 holding.
  • Smith Group Asset Management first reported a position in Medpace in Q3 2018 and has held it in 26 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.